Flourish Research News

Flourish Research, a leading clinical trial company, is pleased to announce the addition of Jose Alvarez as Chief Operating Officer, overseeing the company’s business operation while supporting Flourish’s vision of continued growth and advancement. Read the full release

Flourish Research announces the acquisition of two companies, AMC Research in Charlotte, North Carolina, and Central Research Associates (CRA) in Birmingham, Alabama. AMC is a therapeutically focused Alzheimer’s Disease research site and CRA is a multi-therapeutic site. Both acquisitions complement Flourish’s strategy of acquiring and integrating best-in-class sites. Read the Full Release

As part of this partnership, Flourish Research will align with more than 50 other Global Impact Partners comprised of site networks, sponsors, CROs, and solution providers dedicated to establishing collaborative solutions that improve clinical research processes and ensure site sustainability. Read more

Flourish Research announces the acquisition of Suncoast Research Group, adding to the rapidly expanding Flourish enterprise. Suncoast, which is in the Little Havana community of Miami, FL is a large, multi-therapeutic site aligned with Flourish’s core therapeutic areas of Cardiology/Metabolic, CNS and Vaccines. Read the full release.

Chris Duignan, who has been named Chief Financial Officer of Flourish Research, will build the financial infrastructure, lead financial operations, and integrate the acquisitions of the rapidly growing organization. Read the full release.

Flourish Research announces the acquisition of Keystone Clinical Studies, adding to the rapidly expanding Flourish enterprise. Keystone, which is in the greater Philadelphia area, is a leader in Alzheimer’s Disease and other CNS research and the addition of the site expands Flourish’s reach in these core areas of research. Read the full release.

Reinhold Schulz has been named Chief Executive Officer of Flourish Research, a company designed to acquire, operate, and integrate the best clinical research sites in North America. Flourish operates large, best-in-class sites with experience in Phases I-IV and investigators with deep expertise in key therapeutic areas. Read the full release.